Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study discovers contraception alternative for female cats
"This breakthrough discovery is a major milestone in our quest to provide pet owners with an alternative to surgical spay and neuter" – Gary K. Michelson.
New gene therapy shown to be effective long-term.

Scientists in the USA have demonstrated that a single dose of anti-Müllerian hormone (AMH) gene therapy can produce long-term contraception in female domestic cats.

It is hoped the breakthrough in feline sterilisation will eventually aid efforts to reduce free-roaming cat populations, which can be too large for spaying to be effective. In the USA, for example, there are an estimated 600 million free-roaming domestic cats.

Researchers from the Cincinnati Zoo & Botanical Garden’s Center for Conservation and Research of Endangered Wildlife, the Massachusetts General Hospital, and Horae Gene Therapy Center treated six female cats with a single injection of an adreno-associated viral gene therapy vector with a slightly altered version of the AMH gene.

AMH is a naturally occurring hormone produced by mammals. In cats, it is secreted by ovarian follicles.

After treatment, two four-month long breeding trials were performed, the first after one year and the second after two years. Three untreated cats, used as controls, produced kittens, but none of the cats which had been treated with AMH became pregnant.

During the study, regular health checks found no adverse side effects from the treatment.

Gary K. Michelson, founder and co-chair of the Michelson Found Animals Foundation, which helped fund the study, said: “A non-surgical sterilant for community and companion animals is long overdue and will transform animal welfare. This breakthrough discovery is a major milestone in our quest to provide pet owners with an alternative to surgical spay and neuter.”

As well as helping resolve welfare issues by reducing the number of free-roaming cats, it’s also hoped that controlling numbers will benefit wildlife.

Jenny Gainer, curator of birds and African animals at Cincinnati Zoo & Botanical Garden, said: “Cat predation is a major source of mortality in wild birds. Outdoor cats also contribute indirectly through fear, resource competition, and disease transmission. Controlling and reducing the population of free-roaming cats will make a major difference for declining songbird populations.”

However, it may be a while before the gene therapy is used regularly for feline sterilisation, as there is not currently the right infrastructure in place to mass produce the treatment.

The study has been published in Nature Communications.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
RCVS Regional Question Time heads to Edinburgh

The RCVS is to bring its Regional Question Time (RQT) to Edinburgh for 2026.

The event will take place at Novotel Edinburgh Park in Edinburgh on Wednesday, 20 May 2026.

It will begin with supper and drinks at 6.30pm, with an evening programme from 7.30pm. This will start with an update on RCVS' activities, followed by questions and answers with representatives.

RCVS is encouraging an 'open dialogue', in which queries can be raised in a friendly, informal environment.

While discussions are expected to be audience-led, the RQT is expected address major issues including the VSA, the CMA's remedy package and the VN Vision project.

Tim Parkin, RCVS president, said: "It's an important time for the professions, and I'm looking forward to meeting colleagues in Scotland as we navigate this period of change together so we can come out stronger."

Tickets can be booked here.